456. Dalbavancin, a Long-Acting Lipoglycopeptide...

456. Dalbavancin, a Long-Acting Lipoglycopeptide Antimicrobial Agent, Reduces Length of Stay and Improves Patient Work Productivity in a Hospital Critical Pathway for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)—the ENHANCE ABSSSI Trial

McCarthy, Matthew W, Keyloun, Katelyn R, Gillard, Patrick, Choi, Justin J, Copp, Ronald, Walsh, Thomas J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofz360.529
Date:
October, 2019
File:
PDF, 367 KB
2019
Conversion to is in progress
Conversion to is failed